Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 2

Sponsor

Cancer Type

Head & Neck 4Thoracic 2Other hematologic neoplasm 2Myeloid 2Gynecologic 2CNS 2Tumor-Agnostic 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Metabolic Syndrome 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Diabetes Mellitus 1Cardiovascular Diseases 1

Interventions

Cytarabine 905Cyclophosphamide 899fludarabine 525venetoclax 489fludarabine phosphate 468Azacitidine 460Rituximab 431Methotrexate 419Etoposide 320Filgrastim 299Busulfan 296Dexamethasone 286Vincristine 285Daunorubicin 283Peripheral Blood Stem Cell Transplantation 258Whole-Body Irradiation 243Mycophenolic Acid 232Decitabine 230Granulocyte Colony-Stimulating Factor 227Tacrolimus 220Imatinib Mesylate 211Idarubicin 205Melphalan 202Cyclosporine 182Doxorubicin 177Radiotherapy 169Prednisone 164Dasatinib 163Mitoxantrone 161Lenalidomide 160

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
DNA × Other hematologic neoplasm × Clear all
NCT05605379 2024-08-14

CML Piramid

University Hospital, Bordeaux

Recruiting
88 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00566566 2007-12-03

Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors

Sheba Medical Center

Unknown
150 enrolled
Other hematologic neoplasm

Cardiovascular Diseases, Diabetes Mellitus, Leukemia, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡